Discontinued — last reported Q4 '22
Elevance Health Commercial & Specialty Business Segment — Total net incurred medical claims increased by 7.2% to $8.05B in Q4 2022 compared to the prior quarter. Year-over-year, this metric grew by 5.0%, from $7.66B to $8.05B. This increase may warrant attention — for this metric, lower values are generally preferred.
Higher values relative to revenue indicate lower underwriting margins, while lower values indicate higher profitability.
This is the aggregate of all net medical claims incurred by the Commercial and Specialty segment, encompassing both curr...
Equivalent to total net medical claims expense reported by peer health insurers.
elv_segment_commercial_and_specialty_business_total_net_incurred_medical_claims| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | |
|---|---|---|---|---|---|---|---|
| Value | $6.72B | $7.21B | $7.66B | $6.83B | $7.52B | $7.51B | $8.05B |
| QoQ Change | — | +7.4% | +6.3% | -10.8% | +10.1% | -0.2% | +7.2% |
| YoY Change | — | — | — | — | +12.0% | +4.1% | +5.0% |